Dov Perlysky's most recent trade in Enzo Biochem, Inc. was a trade of 77,101 Stock Option (to acquire Common Stock) done . Disclosure was reported to the exchange on Jan. 11, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enzo Biochem, Inc. | Dov Perlysky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 77,101 | 335,780 | - | - | Stock Option (to acquire Common Stock) |